Banamine: Presence of particles in the affected lot.
Last updated
Summary
Product
Banamine
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Banamine |
Banamine |
DIN 00465305 |
Solution |
50 mg/mL Flunixin, equivalent to 83 mg/mL Flunixin Meglumine |
3511102 |
Issue
Presence of particles in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Users
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies
|
Intervet Canada Corporation. 16750, autoroute Transcanadienne Kirkland (Québec) H9H 4M7 |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74360
Get notified
Receive notifications for new and updated recalls and alerts by category.